Form 4 for AKTX Akari Therapeutics Plc
Accepted 2025-06-16 00:00:00 ET · period of report 2025-06-12 · accession 0000950170-25-086829 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-16 | 2025-06-12+ | AKTX | Gaslightwala Abizer | CEO, Dir | A - Grant | $1.21 | +45.0K | 246.4K | +22% | +$54.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares representing Ordinary Shares | 2025-06-12 | A | A | 20,000 | $1.23 | 221,428 | D | — | — | (F1) Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. (F2) On June 12, 2025, the Reporting Person acquired 20,000 ADS at an average price of $1.23 per ADS. |
| 2 | Common | American Depositary Shares representing Ordinary Shares | 2025-06-13 | A | A | 25,000 | $1.19 | 246,428 | D | — | — | (F1) Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. (F3) On June 13, 2025, the Reporting Person acquired 10,000 ADS at an average price of $1.19 per ADS. |